TABLE 2.

Determinants of enzymatic infarct size.

	β coefficient	[95% CI]	Standardized β	p-value
Age	186.2	[1.237; 371.1]	0.317	0.049
Female sex	−1842	[−7458; 3773]	−0.100	0.499
BMI	−847.7	[−1541; −153.7]	−0.358	0.019
Smoker	4796	[−306.4; 9898]	0.278	0.064
Anterior infarction	5272	[−186; 10732]	0.285	0.058
Symptom to balloon time	9.634	[2.685; 16.58]	0.424	0.009
Culprit lesion MCP-1	36.13	[18.74; 53.51]	0.647	<0.001

MCP-1 levels significantly add to enzymatic infarct size. A multiple linear regression model with CK-MB AUC as outcome variable was calculated (n = 26). The R² for the overall model was 0.667 (adjusted 0.538), which is indicative of a high goodness of fit. The model significantly predicts enzymatic infarct size F(7, 18) = 5.157, p = 0.002. CK-MB AUC, creatinine kinase isoform MB area under the curve.